These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27311570)

  • 41. Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.
    Halle C; Lando M; Svendsrud DH; Clancy T; Holden M; Sundfør K; Kristensen GB; Holm R; Lyng H
    Clin Cancer Res; 2011 Aug; 17(16):5501-12. PubMed ID: 21737508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. XAF1 as a prognostic biomarker and therapeutic target in squamous cell lung cancer.
    Chen YB; Shu J; Yang WT; Shi L; Guo XF; Wang FG; Qian YY
    Chin Med J (Engl); 2011 Oct; 124(20):3238-43. PubMed ID: 22088514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer.
    Ruan J; Mei L; Zhu Q; Shi G; Wang H
    Int J Clin Exp Pathol; 2015; 8(11):15035-8. PubMed ID: 26823841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.
    Zhang Q; Wang XQ; Wang J; Cui SJ; Lou XM; Yan B; Qiao J; Jiang YH; Zhang LJ; Yang PY; Liu F
    Oncotarget; 2015 Jun; 6(17):15095-110. PubMed ID: 25945835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.
    Aubele M; Walch AK; Ludyga N; Braselmann H; Atkinson MJ; Luber B; Auer G; Tapio S; Cooke T; Bartlett JM
    Br J Cancer; 2008 Oct; 99(7):1089-95. PubMed ID: 18781181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of stathmin/op18 as a significant prognostic factor for cervical carcinoma patients.
    Xi W; Rui W; Fang L; Ke D; Ping G; Hui-Zhong Z
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):837-46. PubMed ID: 19034510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
    Kim YB; Kim GE; Pyo HR; Cho NH; Keum KC; Lee CG; Seong J; Suh CO; Park TK
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):822-9. PubMed ID: 15465199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeting protein tyrosine kinase 6 in cancer.
    Gilic MB; Tyner AL
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188432. PubMed ID: 32956764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
    Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
    Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Klotho expression in cervical cancer: differential expression in adenocarcinoma and squamous cell carcinoma.
    Aviel-Ronen S; Rubinek T; Zadok O; Vituri A; Avivi C; Wolf I; Barshack I
    J Clin Pathol; 2016 Jan; 69(1):53-7. PubMed ID: 26209729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.
    Chen HH; Chou CY; Wu YH; Hsueh WT; Hsu CH; Guo HR; Lee WY; Su WC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):658-66. PubMed ID: 21300446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues.
    Aubele M; Spears M; Ludyga N; Braselmann H; Feuchtinger A; Taylor KJ; Lindner K; Auer G; Stering K; Höfler H; Schmitt M; Bartlett JM
    Br J Cancer; 2010 Aug; 103(5):663-7. PubMed ID: 20700126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Zhang L; Huang H; Zhang L; Hou T; Wu S; Huang Q; Song L; Liu J
    BMC Cancer; 2014 Nov; 14():885. PubMed ID: 25427922
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors.
    Peng M; Emmadi R; Wang Z; Wiley EL; Gann PH; Khan SA; Banerji N; McDonald W; Asztalos S; Pham TN; Tonetti DA; Tyner AL
    Oncotarget; 2014 Aug; 5(15):6038-48. PubMed ID: 25153721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
    Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
    PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
    Ye H; Guo X
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31332036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of PTK6 (breast tumor kinase) protein--a prognostic factor for long-term breast cancer survival--is not due to gene amplification.
    Aubele M; Vidojkovic S; Braselmann H; Ritterswürden D; Auer G; Atkinson MJ; Tapio S; Höfler H; Rauser S; Bartlett JM
    Virchows Arch; 2009 Aug; 455(2):117-23. PubMed ID: 19621240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PTK6 regulates IGF-1-induced anchorage-independent survival.
    Irie HY; Shrestha Y; Selfors LM; Frye F; Iida N; Wang Z; Zou L; Yao J; Lu Y; Epstein CB; Natesan S; Richardson AL; Polyak K; Mills GB; Hahn WC; Brugge JS
    PLoS One; 2010 Jul; 5(7):e11729. PubMed ID: 20668531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High Expression of CCDC34 Is Associated with Poor Survival in Cervical Cancer Patients.
    Liu LB; Huang J; Zhong JP; Ye GL; Xue L; Zhou MH; Huang G; Li SJ
    Med Sci Monit; 2018 Nov; 24():8383-8390. PubMed ID: 30458457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.